-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The incidence of pancreatic cysts is usually around 2-15%, mainly including benign cystic lesions, such as pseudocysts and serous cystadenoma, and potentially malignant cysts, such as intraductal papillary mucinous tumors (IPMN) and mucus Cystic tumor (MCN).
The incidence of pancreatic cysts is usually around 2-15%, mainly including benign cystic lesions, such as pseudocysts and serous cystadenoma, and potentially malignant cysts, such as intraductal papillary mucinous tumors (IPMN) and mucus Cystic tumor (MCN).
To complete this study, scientists conducted a retrospective cohort study of American veterans who were diagnosed with pancreatic cysts between 1999 and 2013 .
diagnosis
The results of the study showed that among 7,211 veterans with pancreatic cysts, the researchers followed a total of 31,501 person-years (median follow-up 4.
medsci.
Figure: The probability of pancreatic cancer in patients with pancreatic cysts
This study confirmed that in the cohort of patients with pancreatic cysts, the incidence of pancreatic cancer and the mortality associated with pancreatic cancer were very low.
This study confirmed that in the cohort of patients with pancreatic cysts, the incidence of pancreatic cancer and the mortality associated with pancreatic cancer were very low.
Original source:
Gobind S.
springer.
Leave a message here
